
Lipodisiran, one dose a year to beat genetic cholesterol?
Just one dose of lepodisiran brought down genetic cholesterol levels for nearly a year, marking a potential shift in the treatment of heart disease.
Just one dose of lepodisiran brought down genetic cholesterol levels for nearly a year, marking a potential shift in the treatment of heart disease.
Mycoproteins emerge as a promising alternative to red meat: new studies show improvements for the heart and reduction of cholesterol in just 14 days.
Surprising results from tests of a nanogel-based anti-cholesterol drug: obesity eliminated even in the presence of a fatty diet
This new drug could change the lives of patients with high cholesterol: it is taken orally and works even in low doses.
The arrival of Inclisiran also in Italy is a fundamental step in the fight against cholesterol that cannot be faced with traditional methods.
An extraordinary result of experimental therapies on mice shows how it is possible to reduce high cholesterol by 57% with a single injection. If it works on humans it will be a revolution.